Keyron is a biomedical startup which produces medical devices for obesity, type 2 diabetes, and related comorbidities.
Keyron has raised $30K in total funding. The most recent round was Seed. The last funding was announced in September 2024.
Keyron's investors include Health Wildcatters, LIFTT.
Keyron is headquartered in London, United Kingdom.
Keyron is a biomedical startup which produces medical devices for obesity, type 2 diabetes, and related comorbidities.
Keyron is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Keyron — Funding & Investors." VCBacked, September 6, 2024, https://www.vcbacked.co/company/keyron. Accessed July 25, 2026.
VCBacked. (2024). Keyron — Funding & Investors. Retrieved July 25, 2026, from https://www.vcbacked.co/company/keyron
{{cite web |title=Keyron — Funding & Investors |url=https://www.vcbacked.co/company/keyron |website=VCBacked |access-date=July 25, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated